Mirtazapine-induced hyperpigmentation with type II histopathologic findings

Kumar Sukhdeo; Garrett H Yoon; Lisa Rothman; Shane A Meehan; Melissa K Levin; Randie H Kim

doi:10.1016/j.jdcr.2018.09.022

Mirtazapine-induced hyperpigmentation with type II histopathologic findings

JAAD Case Rep. 2018 Nov 14;4(10):1077-1079. doi: 10.1016/j.jdcr.2018.09.022. eCollection 2018 Nov.

Authors

Kumar Sukhdeo¹, Garrett H Yoon², Lisa Rothman¹, Shane A Meehan¹, Melissa K Levin¹, Randie H Kim¹

Affiliations

¹ Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, New York.
² NYU School of Medicine, New York, New York.

No abstract available

Keywords: DIH, drug-induced hyperpigmentation; drug-induced hyperpigmentation; hyperpigmentation; iron-drug complexes; melanin-drug complexes; mirtazapine.

Publication types

Case Reports